Rosuvastatin attenuates inflammation, apoptosis and fibrosis in a rat model of cyclosporine-induced nephropathy

American Journal of Nephrology

Volumn 37, Issue 1, 2013, Pages 7-15

  Nam, Hyun Kyung ^a   Lee, Seong Joo ^a   Kim, Moo Hyun ^b   Rho, Jee Hyun ^c   Son, Young Ki ^d   Lee, Su Mi ^d   Kim, Seong Eun ^d   Kim, Ki Hyun ^d   An, Won Suk ^d  

^a Busan Medical Center   (South Korea)

^b Dong A University   (South Korea)

^c Mitochondria Hub Regulation Center   (South Korea)

^d Dong A University College of Medicine   (South Korea)

Author keywords

Apoptosis; Cyclosporine; Fibrosis; Inflammation; Rosuvastatin

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CYCLOSPORIN A; DNA NUCLEOTIDYLEXOTRANSFERASE; LIPID; PROTEIN BAX; PROTEIN BCL 2; ROSUVASTATIN; SMAD2 PROTEIN; SMAD3 PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TRANSFORMING GROWTH FACTOR BETA1; UVOMORULIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; ATROPHY; CONTROLLED STUDY; FIBROSING ALVEOLITIS; KIDNEY DISEASE; KIDNEY FIBROSIS; KIDNEY FUNCTION; MALE; NEPHRITIS; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SODIUM RESTRICTION; WESTERN BLOTTING;

ACTINS; ANIMALS; APOPTOSIS; CADHERINS; CYCLOSPORINE; DRUG EVALUATION, PRECLINICAL; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FLUOROBENZENES; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; IMMUNOSUPPRESSIVE AGENTS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; KIDNEY; KIDNEY DISEASES; MALE; MAP KINASE SIGNALING SYSTEM; NITRIC OXIDE SYNTHASE TYPE II; PROTEINS; PYRIMIDINES; RATS; RATS, SPRAGUE-DAWLEY; SMAD PROTEINS; SULFONAMIDES; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84871207774     PISSN: 02508095     EISSN: 14219670     Source Type: Journal    
DOI: 10.1159/000345990     Document Type: Article

References (27)

1. Padi SS, Chopra K: Selective angiotensin II type 1 receptor blockade ameliorates cyclosporine nephrotoxicity. Pharmacol Res 2002; 45: 413-420
2. Myers BD, Sibley R, Newton L, et al: The long-term course of cyclosporine-associated chronic nephropathy. Kidney Int 1988; 33: 590-600
3. Campistol JM, Sacks SH: Mechanisms of nephrotoxicity. Transplantation 2000; 69: SS5-SS10
4. Pichler RH, Franceschini N, Young BA, et al: Pathogenesis of cyclosporine nephropathy: roles of angiotensin II and osteopontin. J Am Soc Nephrol 1995; 6: 1186-1196
5. Shihab FS, Andoh TF, Tanner AM, et al: Role of transforming growth factor-beta 1 in experimental chronic cyclosporine nephropathy. Kidney Int 1996; 49: 1141-1151
6. Thomas SE, Andoh TF, Pichler RH, et al: Accelerated apoptosis characterizes cyclosporine-associated interstitial fibrosis. Kidney Int 1998; 53: 897-908
7. Justo P, Lorz C, Sanz A, Egido J, Ortiz A: Intracellular mechanisms of cyclosporin A-induced tubular cell apoptosis. J Am Soc Nephrol 2003; 14: 3072-3080
8. Moriyama T, Kawada N, Nagatoya K, et al: Fluvastatin suppresses oxidative stress and fibrosis in the interstitium of mouse kidneys with unilateral ureteral obstruction. Kidney Int 2001; 59: 2095-2103
9. Li C, Yang CW, Park JH, et al: Pravastatin treatment attenuates interstitial inflammation and fibrosis in a rat model of chronic cyclosporine-induced nephropathy. Am J Physiol Renal Physiol 2004; 286:F46-F57
10. Ridker PM, Danielson E, Fonseca FA, et al: Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 2008; 359: 2195-2207
11. Lim SW, Hyoung BJ, Piao SG, Doh KC, Chung BH, Yang CW: Chronic cyclosporine nephropathy is characterized by excessive autophagosome formation and decreased autophagic clearance. Transplantation 2012; 94: 218-225
12. Bae EH, Kim IJ, Park JW, Ma SK, Lee JU, Kim SW: Renoprotective effect of rosuvastatin in DOCA-salt hypertensive rats. Nephrol Dial Transplant 2010; 25: 1051-1059
13. Girardi JM, Farias RE, Ferreira AP, Raposo NR: Rosuvastatin prevents proteinuria and renal inflammation in nitric oxide-deficient rats. Clinics (Sao Paulo) 2011; 66: 1457-1462
14. Yang CW, Ahn HJ, Kim WY, et al: Synergistic effects of mycophenolate mofetil and losartan in a model of chronic cyclosporine nephropathy. Transplantation 2003; 75: 309-315
15. Myers BD, Sibley R, Newton L, et al: The long-term course of cyclosporine-associated chronic nephropathy. Kidney Int 1988; 33: 590-600
16. Slattery C, Campbell E, McMorrow T, Ryan MP: Cyclosporine A-induced renal fibrosis: a role for epithelial-mesenchymal transition. Am J Pathol 2005; 167: 395-407
17. Boor P, Ostendorf T, Floege J: Renal fibrosis: novel insights into mechanisms and therapeutic targets. Nat Rev Nephrol 2010; 6: 643-656
18. Lan HY, Chung AC: Transforming growth factor-beta and Smads. Contrib Nephrol. Basel, Karger, 2011, vol 170, pp 75-82
19. Wang W, Koka V, Lan HY: Transforming growth factor-beta and Smad signalling in kidney diseases. Nephrology (Carlton) 2005; 10: 48-56
20. Lagna G, Hata A, Hemmati-Brivanlou A, Massague J: Partnership between DPC4 and SMAD proteins in TGF-beta signalling pathways. Nature 1996; 383: 832-836
21. Amore A, Emancipator SN, Cirina P, et al: Nitric oxide mediates cyclosporine-induced apoptosis in cultured renal cells. Kidney Int 2000; 57: 1549-1559
22. Wolf BB, Green DR: Suicidal tendencies: apoptotic cell death by caspase family proteinases. J Biol Chem 1999; 274: 20049-20052
23. Hockenbery DM, Oltvai ZN, Yin XM, Milliman CL, Korsmeyer SJ: Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 1993; 75: 241-251
24. Oltvai ZN, Milliman CL, Korsmeyer SJ: Bcl-heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 1993; 74: 609-619
25. Buffoli B, Pechanova O, Kojsova S, et al: Provinol prevents CsA-induced nephrotoxicity by reducing reactive oxygen species, iNOS, and NF-B expression. J Histochem Cytochem 2005; 53: 1459-1468
26. Carlos CP, Mendes GE, Miquelin AR, et al: Macrophage depletion attenuates chronic cyclosporine A nephrotoxicity. Transplantation 2010; 89: 1362-1370
27. Di Napoli P, Taccardi AA, Grilli A, et al: Chronic treatment with rosuvastatin modulates nitric oxide synthase expression and reduces ischemia-reperfusion injury in rat hearts. Cardiovasc Res 2005; 66: 462-471.